BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34615385)

  • 1. Peripheral Blood-Based DNA Methylation of Long Non-Coding RNA H19 and Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promoters are Potential Non-Invasive Biomarkers for Gastric Cancer Detection.
    Hu D; Lou X; Meng N; Li Z; Teng Y; Zou Y; Wang F
    Cancer Control; 2021; 28():10732748211043667. PubMed ID: 34615385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancer.
    Wang F; Hu D; Lou X; Wang L; Wang Y; Zhang T; Yan Z; Meng N; Lei Y; Zou Y
    Transl Oncol; 2024 Jun; 44():101929. PubMed ID: 38493517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
    Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
    Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1.
    Li L; Geng Y; Feng R; Zhu Q; Miao B; Cao J; Fei S
    Cell Physiol Biochem; 2017; 42(6):2194-2206. PubMed ID: 28942451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer.
    Yan L; Zhang J; Guo D; Ma J; Shui SF; Han XW
    Int J Oncol; 2019 Jan; 54(1):7-16. PubMed ID: 30387833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
    Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
    Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BNIP3 and DAPK1 methylation in peripheral blood leucocytes are noninvasive biomarkers for gastric cancer.
    Wang F; Hu D; Lou X; Wang Y; Wang L; Zhang T; Yan Z; Meng N; Zou Y
    Gene; 2024 Mar; 898():148109. PubMed ID: 38142898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
    Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
    Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
    Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
    Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
    Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
    Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer.
    Zhang EB; Han L; Yin DD; Kong R; De W; Chen J
    Med Oncol; 2014 May; 31(5):914. PubMed ID: 24671855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non‑coding RNA H19 regulates cell growth and metastasis via the miR‑22‑3p/Snail1 axis in gastric cancer.
    Gan L; Lv L; Liao S
    Int J Oncol; 2019 Jun; 54(6):2157-2168. PubMed ID: 31081061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
    Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
    Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
    Li T; Chen X; Gu M; Deng A; Qian C
    Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
    Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
    J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer.
    Hashad D; Elbanna A; Ibrahim A; Khedr G
    J Clin Lab Anal; 2016 Nov; 30(6):1100-1105. PubMed ID: 27184562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.
    Zhou X; Yin C; Dang Y; Ye F; Zhang G
    Sci Rep; 2015 Jun; 5():11516. PubMed ID: 26096073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
    Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
    Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.